Cassar Lucy, Nicholls Craig, Pinto Alex R, Li He, Liu Jun-Ping
Molecular Signaling Laboratory, Department of Immunology, Central Eastern Clinical School, Monash University, Melbourne, Australia.
FASEB J. 2009 Jun;23(6):1880-92. doi: 10.1096/fj.08-119529. Epub 2009 Feb 4.
Human telomerase reverse transcriptase (hTERT) is central to maintain telomeres for continuous cell proliferation, but it remains unknown how extracellular cues regulate telomerase maintenance of telomeres. Here we report that the cytokine bone morphogenetic protein-7 (BMP7) induces Smad3 phosphorylation, nuclear translocation, and hTERT gene repression. BMP7 induces Smad3-dependent telomerase inhibition in a time- and concentration-dependent manner in breast cancer cells. Chronic exposure of breast cancer cells to BMP7 results in short telomeres, cell senescence, and apoptosis. Mutation of BMPRII receptor, but not TGFbetaRII, ACTRIIA, or ACTRIIB, blocked BMP7-induced repression of the hTERT gene promoter activity, leading to increased telomerase activity, lengthened telomeres, and continued cell proliferation. Expression of hTERT inhibits BMP7-induced breast cancer cell senescence and apoptosis. Thus, our data suggest that BMP7 induces breast cancer cell aging and death by a mechanism involving inhibition of telomerase activity and telomere maintenance via BMPRII receptor- and Smad3-mediated repression of the hTERT gene.
人端粒酶逆转录酶(hTERT)对于维持端粒以实现细胞持续增殖至关重要,但细胞外信号如何调节端粒酶对端粒的维持作用仍不清楚。在此,我们报告细胞因子骨形态发生蛋白7(BMP7)可诱导Smad3磷酸化、核转位及hTERT基因抑制。BMP7在乳腺癌细胞中以时间和浓度依赖性方式诱导Smad3依赖性端粒酶抑制。乳腺癌细胞长期暴露于BMP7会导致端粒缩短、细胞衰老和凋亡。BMPRII受体而非TGFβRII、ACTRIIA或ACTRIIB的突变可阻断BMP7诱导的hTERT基因启动子活性抑制,导致端粒酶活性增加、端粒延长及细胞持续增殖。hTERT的表达可抑制BMP7诱导的乳腺癌细胞衰老和凋亡。因此,我们的数据表明BMP7通过一种机制诱导乳腺癌细胞衰老和死亡,该机制涉及通过BMPRII受体和Smad3介导的hTERT基因抑制来抑制端粒酶活性和端粒维持。